Shiraz Ladiwala
Vermogen: 869 516 $ op 31-05-2026
Vermogen: 869 516 $ op 31-05-2026
Shiraz S.
Ladiwala is currently Lead Independent Director at Mesa Laboratories, Inc. since 2022.
Former positions include Non-Executive Director at Patheon NV and Senior VP-Business Transformation Projects at Thermo Fisher Scientific, Inc. from 2020 to 2021.
Education includes an MBA from the University of Michigan and Stephen M.
Ross School of Business, and an undergraduate degree from the University of Mumbai.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-03-2026 | 8.523 ( 0,15% ) | 869 516 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MESA LABORATORIES, INC. | Directeur/Bestuurslid | 28-10-2021 |
| Bedrijven | Functie | Einde |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 31-03-2021 |
| PATHEON N.V. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Mesa Laboratories, Inc.
Mesa Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures computer-based electronic measurement instruments | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau